The U.S. Food and Drug Administration introduced 21 CFR Part 11 to regulate electronic records and electronic signatures used in several industries, while the European Union’s EudraLex issued Annex 11 to cover computerized systems in pharmaceutical companies producing medicinal products for both human and veterinary use.
This paper outlines the requirements of 21 CFR Part 11 and Annex 11, and provides information on how LabVantage software supports customers in complying with the regulations including:
Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
© 2018 Technology Networks
All rights reserved